Vetiqure AB is a wholly-owned subsidiary of Scandinavian ChemoTech AB, a dynamic Life Science company that focuses on developing technologies and therapies for various tumours and advanced pain control for cancer. The Company has extensive experience in Tumour Specific Electroporation (TSE™), which forms the basis of the Company’s therapeutic areas. Currently, the Company is offering treatments for various forms of tumours. Our product, vetIQure™, is designed for animals based on a technology developed to treat humans. Its TSE technology makes it possible to treat tumours that do not respond to chemotherapy and tumours in sensitive places. The Company headquarter is based at Medicon Village in Lund, Sweden.